Qamzova Injection
Product Images NDC 82972-001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Qamzova (NDC 82972-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nanjing Delova Biotech Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial Carton Label (Carton Label 04)

Vial Carton Label (Carton Label 04)
Packaging label for QAMZOVA (meloxicam) injection, 30 mg/mL, for intravenous use. The label shows the drug is supplied as a 1 mL single-dose vial with instructions to discard unused portion. Manufactured by Nanjing Delova Biotech Co., Ltd. in China. The label includes storage conditions, barcode, and QR code along with dosing and formulation details.*
FDA Label Image

Figure 2 (Clinical Study 02)

Figure 2 (Clinical Study 02)
A line graph comparing pain intensity scores (mean ± SE) over 48 hours for Meloxicam Injection and Placebo. The x-axis shows planned timepoints in hours, and the y-axis shows pain intensity scores from 0 to 10. The graph uses a solid blue line for Meloxicam Injection and a dashed red line for Placebo.*
FDA Label Image

Figure 3 (Clinical Study 03)

Figure 3 (Clinical Study 03)
A line graph comparing pain intensity scores (mean ± SE) over 48 hours between Meloxicam injection and placebo. The x-axis represents planned time points in hours, and the y-axis shows pain intensity scores from 0 to 10. The Meloxicam injection group demonstrates a greater reduction in pain intensity over time compared to the placebo group.*
FDA Label Image

Figure 1: Structural Formula Of Meloxicam (Structure 01)

Figure 1: Structural Formula Of Meloxicam (Structure 01)
Chemical structure of Meloxicam, the active ingredient in QAMZOVA injection. The diagram illustrates the molecular arrangement, highlighting the sulfonamide, hydroxyl, amide, and thiazole groups characteristic of Meloxicam.*
FDA Label Image

Vial Label (Vial Label 05)

Vial Label (Vial Label 05)
Label for QAMZOVA (meloxicam) injection, 30 mg/mL, intended for intravenous use. The label indicates a 1 mL single-dose vial and is manufactured by Nanjing Delova Biotech Co., Ltd. Storage instructions and a statement to discard unused portions are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.